Physician

Brooke E. Daniel, MD

According to 2025 Medicare claims, Brooke Daniel, MD (NPI: 1326096231) practices medical oncology in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Hamilton, TN. This provider's primary affiliated billing organization is TENNESSEE ONCOLOGY PLLC (NPI: 1811955917; TIN: 621647259) and primary practice location at 37404-1130. Daniel is affiliated with the Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Daniel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 794 traditional Medicare patients, billed 144,675 HCPCS/CPT codes, and received $2,362,513 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,448 prescription claims across 318 beneficiaries totaling $3,513,075 in drug costs, led by Revlimid (Lenalidomide). DME data shows 63 claims. Open Payments data shows 82 records totaling $477,249. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $997,190 to $2,362,513. Similarly, Part D prescription costs have risen steadily, from $639,104 to $3,513,075. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,292 and ending at $5,943.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	714	107,651	$997,190
2016	728	111,136	$1,170,273
2017	827	131,476	$1,582,438
2018	851	144,590	$1,648,415
2019	870	172,020	$1,891,669
2020	794	153,585	$1,868,923
2021	842	152,011	$2,110,803
2022	841	144,760	$2,054,018
2023	802	128,885	$1,762,152
2024	794	144,675	$2,362,513

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	226	1,172	$639,104
2016	233	1,192	$783,828
2017	253	1,493	$1,483,436
2018	278	1,590	$2,456,579
2019	286	1,481	$2,884,786
2020	311	1,487	$4,373,645
2021	318	1,538	$4,111,981
2022	343	1,497	$3,315,044
2023	339	1,512	$3,285,307
2024	318	1,448	$3,513,075

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	14	51	$2,722
2016	13	89	$27,219
2017	18	89	$16,185
2018	N/R	57	$7,371
2019	14	111	$8,399
2020	12	154	$11,793
2021	N/R	54	$4,221
2022	12	64	$4,198
2023	N/R	52	$9,682
2024	N/R	63	$3,663

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	299	709	$86
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	247	322	$12
80053	Blood test, comprehensive group of blood chemicals	413	1,221	$10
36415	Insertion of needle into vein for collection of blood sample	418	1,176	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	419	1,383	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	38	1,064	$754,970
Jakafi	Ruxolitinib Phosphate	33	990	$493,927
Calquence	Acalabrutinib Maleate	47	1,410	$492,819
Ibrance	Palbociclib	31	868	$474,601
Kisqali	Ribociclib Succinate	16	448	$237,333

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	15	$1,985
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	11	$525
E0657	Segmental pneumatic appliance for use with pneumatic compressor, chest	Y	N/R	11	$494
J8521	Capecitabine, oral, 500 mg	N	N/R	14	$452
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$207

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$250	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	70	$476,998	PFIZER INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brooke E. Daniel, MD?

Tedicare shows public-source Medicare data for Brooke E. Daniel, MD (NPI 1326096231), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brooke E. Daniel, MD have ACO affiliation data?

Brooke E. Daniel, MD is shown with ACO affiliation data for Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Brooke E. Daniel, MD?

Brooke E. Daniel, MD is linked to TENNESSEE ONCOLOGY PLLC (billing NPI 1811955917) in the available physician profile data.

Does Brooke E. Daniel, MD have Open Payments data?

Brooke E. Daniel, MD has 82 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.